Notable Call Options Activity in Geron

Shares of Geron

are higher on the session by 11.24%, currently trading at $2.97. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average. Options traders are focusing on calls today. A short while ago the October 2011 $3.00 call traded 800 times on open interest of 149 contracts. Calls are outpacing puts today by 50 to 1. Geron Corporation is developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases. Geron is engaged in the discovery and development of therapeutic and diagnostic products for oncology and human embryonic stem cell therapies.